![Michael Sosnowik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 24 932 $ al 30/09/2026
Michael Sosnowik is currently the President of QK Healthcare, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NovelStem International Corp.
 NovelStem International Corp. BiotechnologyHealth Technology Develops stem-cell-based technologies 5,62 % | 31/12/2025 | 2.770.270 ( 5,62 % ) | 24 932 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
QK Healthcare, Inc.
 QK Healthcare, Inc. Drugstore ChainsRetail Trade Manufactures and sells pharmaceutical and other related medical products and services | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
QK Healthcare, Inc.
QK Healthcare, Inc. Drugstore ChainsRetail Trade Manufactures and sells pharmaceutical and other related medical products and services | Retail Trade |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
